New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy

11:00 AM

Author | Nicole Fawcett

rx bottle orange see through person paying in background
Getty Images

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. 

A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

The Inflation Reduction Act, enacted in 2022, included establishing a cap on out-of-pocket spending for those enrolled in Medicare Part D prescription drug plans. 

Researchers from the University of Michigan’s Institute for Healthcare Policy and Innovation and Rogel Cancer Center used the online Medicare Part D Plan Finder tool to assess how much patients were paying for the most commonly prescribed oral chemotherapies. 

They compared data from 2023, when no out-of-pocket cap was in place, to 2024, when the policy first took effect.

SEE ALSO: Free online tool helps prostate cancer patients save on out-of-pocket drug costs

For Medicare Part D beneficiaries, annual out-of-pocket costs for oral cancer medications averaged $11,284 in 2023. 

In 2024, the average annual cost for the same medications is estimated to be $3,927. 

The median cost saving from 2023 to 2024 is estimated to be $7,260, demonstrating the policy’s effect on decreasing costs for patients. 

The study is published in JAMA Network Open.

“People with cancer are already vulnerable to financial distress and medical debt. Our analysis suggests that legislative policy can have a big impact on the cost of cancer care. This is especially critical as lawmakers now consider extending an out-of-pocket cap to commercial insurance,” said lead study author Benjamin Pockros, M.D., M.B.A., a urology resident at Michigan Medicine.

In 2025, an out-of-pocket cap will be set at $2,000, which the researchers predict will result in even greater savings for patients.

Additional authors: Chad Ellimoottil, M.D.; Belal Sbei; Megan Caram, M.D.; Kristian Stensland, M.D., M.P.H., M.S.

Funding: University of Michigan Institute for Healthcare Policy and Innovation.

Paper cited: “Changes in Out-of-Pocket Spending for Common Oral Cancer Medications After the Inflation Reduction Act,” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2024.32456

Sign up for Health Lab newsletters todayGet medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab PodcastAdd us wherever you listen to your favorite shows. 


More Articles About: Prostate Cancer Cancer Treatment Chemotherapy Health Care Delivery, Policy and Economics All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Microscope
Health Lab
Nerve damage reduced in prediabetic mice with diet, exercise
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study.
frozen dial with ice on it with red dial
Health Lab
Enzyme identified as new therapeutic target for “cold” tumors
A study identifies an enzyme as a new therapeutic target for “cold” tumors.
On left, a young boy in a wheelchair has his doctor standing to his left and his parent is standing to his right in a show of support. On the right side of the image, the boy is now an adult and is wondering about the cost of his care and if his questions will be answered.
Health Lab
Changing the definition of cerebral palsy
Cerebral palsy is defined as a childhood disorder, which fails to recognize adults living with the condition and the lack of care they receive once they age out of pediatric clinics.
baby laying down with stethoscope over chest doctors hands
Health Lab
Comparing life threatening illness risk between two surgeries for infants with congenital heart disease
Newly presented data suggest that infants who receive a hybrid stage I palliation – a less invasive alternative for initial treatment – more commonly develop necrotizing enterocolitis compared to those who receive the standard Norwood operation, a complex open heart surgery.
kid screaming with fire coming out of mouth with smoke all around in grey and teddy bear panicked and parents legs on floor as if passed out or blown away
Health Lab
Does your child manage anger well?
One in seven parents think their child gets angrier than peers of the same age and four in 10 say their child has experienced negative consequences when angry, a national poll suggests. 
pigs sick and chickens in background with blue background and green cells floating around
Health Lab
Why the bird flu’s jump to pigs is concerning
A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.